Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Singapore · Delayed Price · Currency is SGD

0.0220

+0.0010 (4.76%)

At close: Oct 23, 2026

Market Cap	37.93M -12.0%
Revenue (ttm)	15.72M +0.1%
Net Income	-23.90M
EPS	-0.02
Shares Out	1.72B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.0220
Previous Close	0.0210
Day's Range	0.0220 - 0.0220
52-Week Range	0.0200 - 0.0890
Beta	-0.07
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. It operates through two segments: Medical Diagnostics and Treatments, and Radiation Therapy and Medical Oncology Services. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; clinical trial services, including PET/CT ... [Read more]

Industry Medical Laboratories

Founded 2011

Employees 104

Stock Exchange Singapore Exchange - Catalist

Ticker Symbol 9G2

Full Company Profile

Financial Performance

In fiscal year 2026, SGXC:9G2's revenue was 15.72 million, an increase of 0.05% compared to the previous year's 15.71 million. Losses were -23.90 million, -11.67% less than in 2025.

Financial Statements